|
 |
Dear %%=ProperCase(FirstName)=%%, Thank you for your interest in Pharmaceutical Technology's content series on Intranasal Drug Delivery: Identifying Challenges & New Product Opportunities. |
| To continue building on what you've learned, we recommend the following article. |
| Emerging Trends and Opportunities in Orally Inhaled Drug Products
Pharmaceutical Technology sat down with Carolyn Berg, Vice President of Business Development, Inhalation, Catalent, and Carla Vozone, Vice President of Strategy Innovation and Partnerships, Catalent, to discuss innovations in orally inhaled drug products, in particular dry powders for inhalation. 
|
Sponsored by: |
